Pfizer (BUE:PFE) Other Net Income (Loss) : ARS-9,879 Mil (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Pfizer Other Net Income (Loss)?

Pfizer's Other Net Income (Loss) for the three months ended in Mar. 2024 was ARS-4,213 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was ARS-9,879 Mil.

Pfizer's quarterly Other Net Income (Loss) declined from Sep. 2023 (ARS4,199 Mil) to Dec. 2023 (ARS-9,386 Mil) but then increased from Dec. 2023 (ARS-9,386 Mil) to Mar. 2024 (ARS-4,213 Mil).

Pfizer's annual Other Net Income (Loss) increased from Dec. 2021 (ARS-43,931 Mil) to Dec. 2022 (ARS1,006 Mil) but then declined from Dec. 2022 (ARS1,006 Mil) to Dec. 2023 (ARS-5,415 Mil).

Pfizer Other Net Income (Loss) Historical Data

The historical data trend for Pfizer's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Other Net Income (Loss) Chart

Pfizer Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

317,816.23

205,810.01

-43,930.65

1,005.90

-5,415.00

Pfizer Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															197.55	-480.00	4,199.40	-9,386.00	-4,212.50

Pfizer Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS-9,879 Mil.

Pfizer Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Pfizer's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Pfizer (BUE:PFE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (BUE:PFE) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

PFE:USA PFE:Peru PFE:Mexico PFE_KZ:Kazakhstan 1PFE:Italy PFEd:UK 0Q1N:UK PFE:Germany PFE:Chile PFE:Canada PFIZ34:Brazil PFE:Austria

Address

66 Hudson Boulevard East, New York, NY, USA, 10001-2192

Website

https://www.pfizer.com

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.